Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.


Search Results to Paul A Bunn

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Bunn, Paul

Item TypeName
Academic Article Secondary screening system for preclinical testing of human lung cancer therapies.
Academic Article Novel bradykinin antagonist dimers for the treatment of human lung cancers.
Academic Article HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer.
Academic Article Future directions in the development of pemetrexed.
Academic Article Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.
Academic Article Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
Academic Article Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines.
Academic Article Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib.
Academic Article Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer.
Academic Article Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
Academic Article Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists.
Academic Article Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
Concept Drug Screening Assays, Antitumor
Concept Drug Evaluation, Preclinical

Search Criteria
  • Drug Evaluation Preclinical

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)